FBRX Forte Biosciences, Inc. Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
11:52
Jul 28
DeItaone Twitter news aggregator (Walter Bloomberg)
Goldman Sachs upgrades CIB to Buy, KeyBanc upgrades FLY to Overweight.
Goldman Sachs upgrades CIB to Buy, KeyBanc upgrades FLY to Overweight, and multiple other analyst upgrades and downgrades are reported across a wide range of stocks with specific price target changes.
FBRX
12:36
Jul 27
Newsquawk Newswire (@Newsquawk)
Pre-market movers include Nvidia discussing a financing backstop for OpenAI's data center.
Pre-market movers include Nvidia discussing a financing backstop for OpenAI's data center, Baker Hughes beating estimates, Rocket Lab winning a Space Force contract, and Fortress Biotech being acquired by Argenx for $77 per share.
FBRX
11:45
Jul 27
zerohedge Financial blog / news aggregator
Premarket movers show Magnificent 7 stocks and AI-related names rallying on falling crude.
Premarket movers show Magnificent 7 stocks and AI-related names rallying on falling crude prices, while D-Wave Quantum, Ford, Forte Biosciences, General Motors, and Gossamer Bio gain on specific catalysts and MapLight Therapeutics plunges on trial results.
FBRX
05:59
Jul 27
seedy19tron Biotech trader, L/S
Author highlights Affinity's golden run in biotech and their top 5 FBRX holding post-APGE.
Author highlights Affinity's golden run in biotech and their top 5 FBRX holding post-APGE acquisition, celebrating broad sector gains without explicit forward calls on most names.
FBRX
LOW
05:48
Jul 27
seedy19tron Biotech trader, L/S
The tweet highlights recent M&A activity in biotech involving ARGX and FBRX.
The tweet highlights recent M&A activity in biotech involving ARGX and FBRX, celebrating gains for FBRX longs and noting a flurry of deals in the sector.
FBRX
LOW
19:52
Jul 09
Martin Shkreli Investor / Podcast host
Author recalls a failed short attempt on FBRX, no current position or forward thesis.
FBRX
LOW

About FBRX Analyst Coverage

Buzzberg tracks FBRX (Forte Biosciences, Inc.) across 5 sources. 0 bullish vs 0 bearish calls from 5 analysts. Sentiment: evenly split. 6 total trade ideas tracked. Latest voices: DeItaone, Newsquawk, zerohedge.